A novel direct co-culture assay analyzed by multicolor flow cytometry reveals context- and cell type-specific immunomodulatory effects of equine mesenchymal stromal cells.
Authors: Hillmann Aline, Paebst Felicitas, Brehm Walter, Piehler Daniel, Schubert Susanna, Tárnok Attila, Burk Janina
Journal: PloS one
Summary
# Editorial Summary Mesenchymal stromal cells (MSCs) are increasingly used in equine regenerative medicine, yet their immunomodulatory mechanisms remain incompletely understood—particularly how they interact with specific immune cell populations under different inflammatory conditions. Researchers developed a sophisticated direct co-culture system using multicolour flow cytometry to assess how equine adipose-derived MSCs influenced various leukocyte subsets when exposed to different activation stimuli (ConA for mild activation, PMA/ionomycin for strong activation). MSCs demonstrated nuanced, context-dependent effects: whilst they failed to suppress cytokine production in strongly activated T cells, they enhanced regulatory T cell differentiation, reduced cytokine output from B cells and granulocytes across most conditions, and reversed monocyte interferon-γ production in mildly activated cultures. The data revealed two distinct suppressive mechanisms—IL-10 production dominated in mild to moderate inflammation, whereas prostaglandin E2 (PGE2) became the likely mediator in highly inflammatory environments, suggesting MSCs employ different immunomodulatory strategies depending on the inflammatory milieu. These findings have important implications for clinical application: the efficacy of MSC therapies may vary substantially depending on the type and severity of inflammation present at the treatment site, which should inform both case selection and post-injection management protocols in equine practice.
Read the full abstract on PubMed
Practical Takeaways
- •MSC immunomodulatory capacity varies depending on the inflammatory environment—they work differently in mild versus severe inflammation, so clinical context matters when considering MSC therapies
- •The identification of IL-10 and PGE2 as key modulatory molecules provides targets for optimizing MSC preparations and predicting therapeutic efficacy in different inflammatory conditions
- •This assay method offers a rigorous framework for testing and comparing MSC batches before clinical use, potentially improving consistency and outcomes of regenerative treatments
Key Findings
- •MSC supported regulatory T cell differentiation (increased CD25/FoxP3+ cells) in PMA/I-activated cultures despite no suppression of T cell cytokine production
- •MSC reduced cytokine-producing B cells and granulocytes across different activation states through IL-10 and PGE2 mechanisms
- •MSC immunomodulatory effects were context-specific: IL-10 production occurred with non-stimulated/ConA-activated leukocytes, while PGE2 predominated in strongly inflammatory (PMA/I) conditions
- •The established multicolor flow cytometry assay successfully characterized cell-type-specific immune interactions and could serve as a functional potency assay for MSC quality evaluation